DEMOCRATIC REPUBLIC OF THE CONGO / RankWire.AI / – Since the outbreak’s onset, Congo’s Ebola outbreak has surged at an unprecedented rate compared to previous epidemics in the country. As of August 3, officials confirmed 3,874 cases and 1,751 deaths. This marks Congo’s largest documented Ebola outbreak and the second largest worldwide. The nation reached 1,000 cases within just 40 days of initiating its response, a stark contrast to a major outbreak starting in 2018, which took roughly 235 days to reach that milestone.

Health authorities officially announced the outbreak on May 15, after laboratories identified the Bundibugyo virus in Ituri province. Later investigations uncovered evidence that infections had begun months earlier near Mongbwalu. Early symptoms in patients often resembled malaria or other common illnesses, which delayed initial detection. Laboratory testing initially focused on the more well-known Zaire Ebola species. This delay allowed the virus additional time to spread extensively through households, clinics, mining regions, and trading hubs before testing and isolation efforts could be scaled up.
The presence of the Bundibugyo strain has also restricted available medical countermeasures. While approved Ebola vaccines and antibody therapies target Zaire ebolavirus—the strain responsible for Congo’s 2018 to 2020 epidemic—no licensed vaccine or proven specific treatment exists for Bundibugyo virus disease. Responders must depend on rapid diagnostic testing, patient isolation, supportive care, infection prevention measures, and safe burial practices. Although the World Health Organization has supported new diagnostic capabilities and treatment research, these initiatives only began after transmission had already extended into multiple regions.
Delayed detection hampered contact tracing efforts
Since its emergence, the outbreak has extended beyond Mongbwalu into numerous health zones across eastern and northeastern Congo. Ituri remains the epicenter, with cases also reported in North Kivu, South Kivu, Haut-Uele, and Tshopo. By July 30, response teams monitored 17,863 contacts. However, follow-up rates have been inconsistent, especially in provinces affected by insecurity and logistical challenges. Authorities have also identified many new patients outside of established contact lists, indicating surveillance teams have not captured every transmission chain.
Ongoing conflict has further complicated case detection and treatment efforts. Armed attacks have blocked roads, disrupted health activities, and led to temporary suspensions of field operations. Additionally, large populations moving between mining sites, markets, towns, and displacement camps make daily contact monitoring difficult. Healthcare facilities face shortages of protective gear, trained personnel, transportation, and laboratory access. As of July 30, Congo reported 151 infections and 44 deaths among health workers, heightening pressure on an already strained response system.
Inadequate vaccination coverage and ongoing insecurity fuel the outbreak
Transmission of Ebola occurs through direct contact with the blood or bodily fluids of an infected individual. Risks are heightened in homes, clinics, and during burials where infection controls are lacking. Over 60% of recent fatalities occurred outside of treatment centers, complicating safe burials and contact tracing efforts. In response, Congo’s health ministry, the World Health Organization, and Africa CDC have increased laboratory testing, established additional treatment sites, enhanced border screening, and expanded public outreach. Despite these efforts, the response still struggles to keep pace with the rapid and widespread transmission of new cases.
Meanwhile, Uganda concluded its linked outbreak on July 28 after 42 days without new local cases. France has also declared the end of secondary spread from its single treated case. Nonetheless, Congo remains the primary hub of sustained transmission, with a death rate close to 45% in early August. The outbreak’s accelerated pace is due to late detection and the absence of strain-specific vaccines and treatments. Factors such as missed contacts, ongoing conflict, personnel shortages, and population mobility have all contributed to the wider spread, making this Bundibugyo epidemic distinct from earlier Ebola outbreaks in Congo.
